Wealth Enhancement Advisory Services »

Takeda Pharmaceutical shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.6M 125k 12.94
2024-03-31 $1.8M 131k 13.89
2023-12-31 $1.9M 130k 14.27
2023-09-30 $2.1M 136k 15.47

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Msci Intl Moment (IMTM)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Alps Etf Tr Smith Core Plus (SMTH)
Schwab Strategic Tr Fundamental Intl (FNDF)
Amazon (AMZN)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Mondrian Investment Partners
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Renaissance Technologies
First Trust Advisors
Brandes Investment Partners
Van Eck Associates Corp.
BlackRock
Citadel Advisors
Northern Trust
Managed Asset Portfolios
Envestnet Asset Management
BlackRock

View all funds holding Takeda Pharmaceutical